166 related articles for article (PubMed ID: 33456107)
1. THE Role of Preoperative carcinoembryonic antigen in recurrence of resectable colorectal carcinoma.
Khan MA; Maken RN; Nisar H; Fatima I; Khan IU; Masood M; Shahid AB
Acta Clin Croat; 2020 Jun; 59(2):216-222. PubMed ID: 33456107
[TBL] [Abstract][Full Text] [Related]
2. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
3. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
5. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
Veingerl B
Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Carcinoembryonic Antigen (CEA) in Detecting Colorectal Cancer Recurrence Depending on Its Preoperative Level.
Lee TH; Kim JS; Baek SJ; Kwak JM; Kim J
J Gastrointest Surg; 2023 Aug; 27(8):1694-1701. PubMed ID: 37407895
[TBL] [Abstract][Full Text] [Related]
7. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
9. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study.
Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T
Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674
[TBL] [Abstract][Full Text] [Related]
10. [The value of tumor markers in colorectal cancer].
Peters KM; Grundmann R
Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
[TBL] [Abstract][Full Text] [Related]
11. Monitoring carcinoembryonic antigen in colorectal cancer: is it still useful?
Li Destri G; Greco S; Rinzivillo C; Racalbuto A; Curreri R; Di Cataldo A
Surg Today; 1998; 28(12):1233-6. PubMed ID: 9872539
[TBL] [Abstract][Full Text] [Related]
12. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.
Su BB; Shi H; Wan J
World J Gastroenterol; 2012 May; 18(17):2121-6. PubMed ID: 22563201
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.
Nakamura Y; Shida D; Tanabe T; Takamizawa Y; Imaizumi J; Ahiko Y; Sakamoto R; Moritani K; Tsukamoto S; Kanemitsu Y
Cancer Med; 2020 Jan; 9(2):653-662. PubMed ID: 31799750
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen: its value in the follow-up of patients with colorectal cancer.
Rockall TA; McDonald PJ
Int J Colorectal Dis; 1999 Feb; 14(1):73-7. PubMed ID: 10207736
[TBL] [Abstract][Full Text] [Related]
16. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
[TBL] [Abstract][Full Text] [Related]
17. Role of carcinoembryonic antigen as a marker for colorectal liver metastases.
Jones C; Badger SA; Epanomeratikis E; McKie LD; Diamond T; Taylor MA
Br J Biomed Sci; 2013; 70(2):47-50. PubMed ID: 23888604
[TBL] [Abstract][Full Text] [Related]
18. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer.
Irvine T; Scott M; Clark CI
Colorectal Dis; 2007 Jul; 9(6):527-31. PubMed ID: 17573747
[TBL] [Abstract][Full Text] [Related]
19. Value of carcinoembryonic antigen in the management of colorectal cancer.
Wang JY; Tang R; Chiang JM
Dis Colon Rectum; 1994 Mar; 37(3):272-7. PubMed ID: 8137675
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer.
Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D
Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
